El XXIII GEIS International Symposium se celebrará en Zaragoza el viernes 3 de octubre.
PROGRAM
9:00-9:10 WELCOME & INTRODUCTION
Mr. José Luis Bancalero Flores, Consejero de Sanidad del Gobierno de Aragón
Dr. Javier Martínez Trufero, Miguel Servet University Hospital, Zaragoza
Dr. Mª Carmen Gómez, Miguel Servet University Hospital, Zaragoza
Dr. Claudia Valverde, GEIS President
9:10-9:55 SESSION 1. FOCUSING ON OUR RESEARCHERS: AN OVERVIEW OF GEIS-BUESA GRANTS
9:15-9:25 And the winner is... By TBC and Enara Alakano
9:25-9:35 Buesa grant 2025: new award
9:35-9:45 Enara-GEIS Leiomyosarcoma Grant
9:45-9:55 Buesa grant 2023. Virtual biopy: non-invasive diagnostic and follow up in osteosarcoma through immunodirected-image.
Dr. Alberto Jiménez Schuhmacher
10:00-11:20 SESSION 2. SARCOMA SUBTYPE HIGHLIGHTED: CHONDROSARCOMA
Chairs: Dr. Laura Jiménez, Duran i Reynals University Hospital, L'Hospitalet de Llobregat (Barcelona)
Dr. Cleofé Romagosa, Vall d'Hebron University Hospital, Barcelona
10:00-10:10 Interactive clinical case
Dr. Ana Paisán, Hospital Universitario Donostia, San Sebastián (Guipúzcoa)
10:15-10:30 Pathology insights
Dr. Fernanda Amary. Royal National Orthopaedic Hospital, NHS Trust, London, United Kingdom
10:30-10:45 Surgical challenges
Dr. Luis Javier Floría, Miguel Servet University Hospital, Zaragoza
10:45-11:00 New treatment opportunities
Dr. William Tap, Memorial Sloan Kettering Cancer Center, New York (NY), USA
11:00-11:20 Discussion
11:20-11:40 COFFEE BREAK
11:40-13:10 SESSION 3. LET’S IMPROVE: OTHER BONE TUMORS
Chairs: Dr. Cristina Mata, Gregorio Marañón General University Hospital, Madrid
Dr. Isidro Gracia, De la Santa Creu i Sant Pau Hospital, Barcelona
11:45-12:00 The Boom Birmingham consensus
TBC
12:00-12:15 New treatment opportunities in osteosarcoma
Dr. Shreyas Patel, The University of Texas MD Anderson Cancer Center, Houston (TX), USA
12:15-12:30 Any news for chordoma?
Dr. Nadia Hindi, Fundación Jiménez Díaz University Hospital, Madrid
12:30-12:45 Has maintenance treatment any role in Ewing sarcoma?
TBC
12:45-13:10 Discussion
13:15-14:00 LUNCH BREAK
14:00-15:05 SESSION 4. THE PATIENT´S VOICE
Chairs: Dr. Mª Angeles Sala, Basurto University Hospital, Basurto (Vizcaya)
TBC
Mr. Aurelio Vicente, APSATUR
Ms. Mª Teresa Deus, ASARGA
14:00-14:10 8 years of CSUR: how the story started
Dr. Javier Martín Broto. Fundación Jiménez Díaz. Madrid
14:10-14:20 Making things a bit easier: eSarcoma Platform
TBC
14:20-14:30 Reaching where the public system does not: Domum Program
Beatriz Puig, Fundación Privada Nous Cims, Barcelona
14:30-14:45 How to deal when there's no more treatment left
Ms. María Susmozas, Asociación Iker
14:45-15:05 Discussion
Discussants: representatives of patients' associations (VYDA, FMPJC, APSATUR, ASARGA, Asociación Iker, FEPNC)
15:10-16:25 SESSION 5. FOCUSING ON BIOMARKERS
Chairs: Dr. Raquel Correa
Dr. José Alejandro Pérez Fidalgo, Hospital Clínico Universitario de Valencia
15:10- 15:25 Predictive biomarkers for systemic treatment response and toxicity in Sarcoma
Dr. Massimo Serra, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy
15:25-15:40 Are there biomarkers for radiotherapy?
Dr. Josep Isern, De la Santa Creu i Sant Pau University Hospital, Barcelona
15:40-15:55 High-throughput omics to define sarcoma heterogeneity
Dr. Paul Huang, Institute of Cancer Research, London (United Kingdom)
15:55-16:10 Are we ready to change clinical practice? GIST liquid biopsy
Dr. César Serrano. Hospital Vall d´Hebrón. Barcelona
16:10-16:25 Discussion
16:25-16:40 Coffee break
16:40-17:45 SESSION 6. CHALLENGING ISSUES
Chairs: Dr. Gloria Marquina, San Carlos Clinical Hospital, Madrid
Dr. José Manuel Asencio, Gregorio Marañón General University Hospital, Madrid
16:45-17:00 Dealing with vascular structures in retroperitoneal sarcomas
Dr. Hugo Vasques. Instituto Português de Oncologia, Lisboa, Portugal
17:00-17:15 Kaposi management in modern times
Dr. Robert Maki, Memorial Sloan Kettering Cancer Center, New York (NY), USA
17:15-17:30 New systemic treatments in angiosarcoma
TBC
17:30-17:45 Discussion
17:45-17:50 FAREWELL
Dr. Javier Martínez Trufero, Miguel Servet University Hospital, Zaragoza
Dr. Mª Carmen Gómez, Miguel Servet University Hospital, Zaragoza
Dr. Claudia Valverde, Vall d'Hebron University Hospital, Barcelona
Venue:
Caixa Forum Zaragoza
Avda. de Anselmo Clavé, 4, 50004 Zaragoza
Language:
English and Spanish. Simultaneous translation will be available.
Technical Secretariat:
Grupo Español de Investigación en Sarcoma
E-mail: eventos(at)grupogeis.org
Con la colaboración de:
